↓ Skip to main content

Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer

Overview of attention for article published in Frontiers in oncology, December 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
Published in
Frontiers in oncology, December 2022
DOI 10.3389/fonc.2022.1054086
Pubmed ID
Authors

Li Huifang, Gao Jie, Feng Yi

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 7%
Other 2 7%
Researcher 2 7%
Lecturer 1 3%
Student > Bachelor 1 3%
Other 3 10%
Unknown 19 63%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Unspecified 2 7%
Nursing and Health Professions 2 7%
Biochemistry, Genetics and Molecular Biology 1 3%
Social Sciences 1 3%
Other 1 3%
Unknown 19 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2022.
All research outputs
#15,049,328
of 26,180,771 outputs
Outputs from Frontiers in oncology
#3,913
of 22,919 outputs
Outputs of similar age
#194,693
of 492,925 outputs
Outputs of similar age from Frontiers in oncology
#227
of 1,472 outputs
Altmetric has tracked 26,180,771 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,925 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 1,472 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.